Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 69

Cited In for PubMed (Select 11713364)

1.

Pneumonia in the neutropenic cancer patient.

Evans SE, Ost DE.

Curr Opin Pulm Med. 2015 May;21(3):260-71. doi: 10.1097/MCP.0000000000000156. Review.

PMID:
25784246
2.

The comparative development of elevated resistance to macrolides in community-acquired pneumonia caused by Streptococcus pneumoniae.

Yayan J.

Drug Des Devel Ther. 2014 Oct 3;8:1733-43. doi: 10.2147/DDDT.S71349. eCollection 2014.

3.

Can we predict which patients with community-acquired pneumonia are likely to have positive blood cultures?

Campbell SG, McIvor RA, Joanis V, Urquhart DG.

World J Emerg Med. 2011;2(4):272-8. doi: 10.5847/wjem.j.1920-8642.2011.04.005.

4.
5.

I-ROAD could be efficient in predicting severity of community-acquired pneumonia or healthcare-associated pneumonia.

Matsunuma R, Asai N, Ohkuni Y, Nakashima K, Iwasaki T, Misawa M, Norihiro K.

Singapore Med J. 2014 Jun;55(6):318-24.

6.

Efficacy and safety of levofloxacin in the context of other contemporary fluoroquinolones: a review.

Ball P.

Curr Ther Res Clin Exp. 2003 Nov;64(9):646-61. doi: 10.1016/j.curtheres.2003.11.003.

7.

Amoxicillin for acute lower respiratory tract infection in primary care: subgroup analysis of potential high-risk groups.

Moore M, Stuart B, Coenen S, Butler CC, Goossens H, Verheij TJ, Little P; GRACE consortium.

Br J Gen Pract. 2014 Feb;64(619):e75-80. doi: 10.3399/bjgp14X677121. Erratum in: Br J Gen Pract. 2014 Mar;64(620):126.

8.

Respiratory virus surveillance in hospitalised pneumonia patients on the Thailand-Myanmar border.

Turner P, Turner C, Watthanaworawit W, Carrara V, Cicelia N, Deglise C, Phares C, Ortega L, Nosten F.

BMC Infect Dis. 2013 Sep 16;13:434. doi: 10.1186/1471-2334-13-434.

9.

Etiology and Anti-microbial Sensitivity of Organisms Causing Community Acquired Pneumonia: A Single Hospital Study.

Menon RU, George AP, Menon UK.

J Family Med Prim Care. 2013 Jul;2(3):244-9. doi: 10.4103/2249-4863.120728.

10.

Burr hole evacuation for infratentorial subdural empyema.

Alimehmeti R, Seferi A, Stroni G, Sallavaci S, Rroji A, Pilika K, Petrela M.

World J Clin Cases. 2013 Aug 16;1(5):172-5. doi: 10.12998/wjcc.v1.i5.172.

11.

Analysis of the severity and prognosis assessment of aged patients with community-acquired pneumonia: a retrospective study.

Xiao K, Su LX, Han BC, Yan P, Yuan N, Deng J, Li J, Xie LX.

J Thorac Dis. 2013 Oct;5(5):626-33. doi: 10.3978/j.issn.2072-1439.2013.09.10.

12.

The role of complications of community acquired pneumonia on the outcome of the illness: a prospective observational study in a tertiary institution in eastern Nigeria.

Mbata G, Chukwuka C, Onyedum C, Onwubere B, Aguwa E.

Ann Med Health Sci Res. 2013 Jul;3(3):365-9. doi: 10.4103/2141-9248.117952.

13.

Incidence of community-acquired lower respiratory tract infections and pneumonia among older adults in the United Kingdom: a population-based study.

Millett ER, Quint JK, Smeeth L, Daniel RM, Thomas SL.

PLoS One. 2013 Sep 11;8(9):e75131. doi: 10.1371/journal.pone.0075131. eCollection 2013.

14.
15.

Clinical and economic burden of community-acquired pneumonia among adults in the Czech Republic, Hungary, Poland and Slovakia.

Tichopad A, Roberts C, Gembula I, Hajek P, Skoczynska A, Hryniewicz W, Jahnz-Rozyk K, Prymula R, Solovič I, Kolek V.

PLoS One. 2013 Aug 6;8(8):e71375. doi: 10.1371/journal.pone.0071375. Print 2013.

16.
17.

Current management of patients hospitalized with community-acquired pneumonia across Europe: outcomes from REACH.

Blasi F, Garau J, Medina J, Ávila M, McBride K, Ostermann H; REACH study group.

Respir Res. 2013 Apr 15;14:44. doi: 10.1186/1465-9921-14-44.

18.

The potential anesthetic threats, challenges and intensive care considerations in patients with HIV infection.

Bajwa SJ, Kulshrestha A.

J Pharm Bioallied Sci. 2013 Jan;5(1):10-6. doi: 10.4103/0975-7406.106554.

19.

Non-HIV Pneumocystis pneumonia: do conventional community-acquired pneumonia guidelines under estimate its severity?

Asai N, Motojima S, Ohkuni Y, Matsunuma R, Nakasima K, Iwasaki T, Nakashita T, Otsuka Y, Kaneko N.

Multidiscip Respir Med. 2012 Jun 11;7(1):2. doi: 10.1186/2049-6958-7-2.

20.

Switch therapy in hospitalized patients with community-acquired pneumonia: tigecycline vs. levofloxacin.

Ramirez JA, Cooper AC, Wiemken T, Gardiner D, Babinchak T; 308 Study Group.

BMC Infect Dis. 2012 Jul 19;12:159. doi: 10.1186/1471-2334-12-159.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk